Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin. - Wikidata - awgldk - TriplyDB

Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.

Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.

http://www.wikidata.org/entity/Q37200835

about

Safety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi's sarcoma.Development of nanoscale approaches for ovarian cancer therapeutics and diagnostics Clinical characteristics, predictors of immune reconstitution inflammatory syndrome and long-term prognosis in patients with Kaposi sarcoma.Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study.Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.Viral profiling identifies multiple subtypes of Kaposi's sarcoma.Oral squamous cell carcinoma in a patient treated with long-term pegylated liposomal doxorubicin for recurrent ovarian cancer.Pathology of Kaposi's Sarcoma-Associated Herpesvirus Infection Gastrointestinal Kaposi's sarcoma: Case report and review of the literature.A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy.Squamous cell carcinoma of the oral cavity in nonsmoking women: a new and unusual complication of chemotherapy for recurrent ovarian cancer?Squamous cell carcinomas of the tongue and oral cavity as secondary malignancies: what factors are implicated?HIV-1 Evolutionary Patterns Associated with Metastatic Kaposi's Sarcoma during AIDS.Advances in the systemic treatment of cutaneous sarcomas.Squamous cell carcinoma of the oral tongue in two patients previously exposed to long-term pegylated liposomal doxorubicin.VEGF-mediated tight junctions pathological fenestration enhances doxorubicin-loaded glycolipid-like nanoparticles traversing BBB for glioblastoma-targeting therapy.HIV-associated Kaposi's sarcoma in Maputo, Mozambique: outcomes in a specialized treatment center, 2010-2015.Oral leukoplakia, a precancerous lesion of squamous cell carcinoma, in patients with long-term pegylated liposomal doxorubicin treatment.[Profile of Kaposi sarcoma patients in the competence network HIV/AIDS].Cancer incidence in Nigeria: a report from population-based cancer registries.A retrospective analysis of AIDS-associated Kaposi's sarcoma in patients with undetectable HIV viral loads and CD4 counts greater than 300 cells/mm(3).Human Herpes Virus 8 in HIV-1 infected individuals receiving cancer chemotherapy and stem cell transplantation.Ten-year survival among HIV-1-infected subjects with AIDS or non-AIDS-defining malignancies

P2860

Q30380999-1394BABD-F1C9-4FA4-B1E8-C3F2A486C9BD Q30421664-2EC3E5E3-D6D7-4327-93CC-4AFD27FDA156 Q33442216-BACA97F8-5199-4BBE-B0EC-AC95E4C738AF Q33651611-D93F5E31-ED71-4037-AD9E-C2920E9AFD2C Q34168712-AA2A7E40-4BFE-4B59-902B-676CA0744539 Q34237734-A7613974-376D-45E4-AB14-A5A9F2ADF26B Q35015808-A4EFA82C-CC53-4EDE-99BC-FE77016AD28B Q35179783-50E1BFC8-7E19-48D0-9F69-544F73B72818 Q35922027-740737B3-1891-4CF2-B917-45439CE0DA59 Q35989731-00F0074B-27D0-4CD3-A500-255321C2AFAD Q36058281-F8C84218-CE53-41B8-A222-8B6A9831E7AF Q36483169-30B47B17-9B36-4A4A-975E-1FC53C89E1B2 Q36714359-A50B4A52-5ECA-4BFC-B55E-C87ABB113840 Q37250125-6492D31E-DF6D-439E-BFF3-6B1846F98D72 Q38000872-1F0A5E44-B071-4281-ABAC-162DC562293C Q42425711-4899149A-0186-4C18-9753-209F95243B37 Q47357133-6A95AC95-5C18-42CA-9B7A-9D0B85299FEE Q49232494-B09BCC0A-1FAC-4B2F-818D-75A1E480FA7E Q50003156-CB56FC3F-2EB4-4B50-A463-5928A42B1A1B Q50173084-AACF8344-FDDE-4D01-A4D1-2F821D9B1515 Q50590113-A8701ECA-35AC-4465-9EDB-9DE40C9682F3 Q53374076-42E1DA23-27D9-4639-AF38-E54000603D3E Q54215898-C85FFCF5-E410-4C64-9DEB-AC3654630BAB Q58290740-5EE2F185-C109-441B-85FC-32714B19086D

P2860

Long-term prognosis of HIV-infected patients with Kaposi sarcoma treated with pegylated liposomal doxorubicin.

http://www.wikidata.org/entity/Q37200835

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Long-term prognosis of HIV-inf ...... gylated liposomal doxorubicin.

@en

Long-term prognosis of HIV-inf ...... gylated liposomal doxorubicin.

@nl

type

label

Long-term prognosis of HIV-inf ...... gylated liposomal doxorubicin.

@en

Long-term prognosis of HIV-inf ...... gylated liposomal doxorubicin.

@nl

prefLabel

Long-term prognosis of HIV-inf ...... gylated liposomal doxorubicin.

@en

Long-term prognosis of HIV-inf ...... gylated liposomal doxorubicin.

@nl

P1433

Q37200835-C2ECD03A-9EC4-4428-850B-8213F1FCE45F

P1476

Q37200835-43259C63-37D3-4351-B873-C8B6DE358C19

P2093

Q37200835-27099C0B-11D2-45FA-BFE6-31190CF22542

Q37200835-2D063ECA-BC12-4748-9163-4D7A046618FA

Q37200835-31524253-E9B9-4257-8CED-4A15579BDFE7

Q37200835-4204A0F7-FD5D-4A43-B8AB-A1CBB0F5F4E4

Q37200835-44B07333-4866-4822-93B3-13F15AED3724

Q37200835-5E0C4ABA-E07F-47B2-82CB-0661E9732C41

Q37200835-64141FD5-F1C4-4535-8AEC-88004F3E7519

Q37200835-7F43764D-F022-413F-809A-A83AD22FDC87

Q37200835-920672BF-D6E1-45AD-8638-44CC541980AB

Q37200835-954221D4-C98E-40B7-9097-67DF0A5DF3AD

P2860

Q37200835-19C9CA6A-D2A4-4650-95AC-78CD691B245A

Q37200835-21939894-D217-45A2-9CC5-DE02D6C294B0

Q37200835-25391D11-63AA-4DBC-A5AB-0FF2BE5C5174

Q37200835-38033D1D-8C2E-44D8-B4AF-457E8DEDB60A

Q37200835-402E2E74-03EE-4470-A10C-375093B4A712

Q37200835-4C34C8BD-0AF6-401D-82B3-298D89CDFF8D

Q37200835-4D0DA64C-936D-4DB3-89E7-5D80FDE1B105

Q37200835-89CBF34C-CF39-4B45-B943-B085452DDB49

Q37200835-8C3865CA-7E95-497B-8B2C-793BBD4C86AE

Q37200835-AAC99AB3-FA47-44D3-8FFE-02B545FCF6D0

P304

Q37200835-80B6E531-6588-4051-91C3-BB14A51A02D6

P31

Q37200835-9AB6E000-68BB-448B-937B-0389B92CA041

P356

Q37200835-B1DDAD7C-28DE-46F3-A3C5-46FD4BA51DC3

P407

Q37200835-328E2E12-FC9E-4A91-A069-7B3399054CB2

P433

Q37200835-5BC778E0-D8BE-4DC2-8557-BC7671555623

P478

Q37200835-28AE9105-2830-4496-8C71-6595996967E7

P577

Q37200835-47F6B17D-C182-473E-874E-127CB2D8D02D

P5875

Q37200835-58276DE8-D290-4E29-835F-739665B016C9

P698

Q37200835-2DF06D20-3D8D-4934-A348-89E80E457204

P921

Q37200835-34AB2AE5-2B1F-4396-8062-ED932D4A4942

P356

P1433

Clinical Infectious Diseases

P1476

Long-term prognosis of HIV-inf ...... gylated liposomal doxorubicin.

@en

P2093

A Goyenechea

http://www.w3.org/2001/XMLSchema#string

A Ocampo

http://www.w3.org/2001/XMLSchema#string

Caelyx/Kaposi's Sarcoma Spanish Group

http://www.w3.org/2001/XMLSchema#string

D Podzamczer

http://www.w3.org/2001/XMLSchema#string

E Valencia

http://www.w3.org/2001/XMLSchema#string

F Baldobí

http://www.w3.org/2001/XMLSchema#string

G Sirera

http://www.w3.org/2001/XMLSchema#string

I Santos

http://www.w3.org/2001/XMLSchema#string

J González del Castillo

http://www.w3.org/2001/XMLSchema#string

J González-Lahoz

http://www.w3.org/2001/XMLSchema#string

P2860

Polyethylene glycol-liposomal doxorubicin: a review of its use in the management of solid and haematological malignancies and AIDS-related Kaposi's sarcoma.

A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma.

Trends in cancer risk among people with AIDS in the United States 1980-2002.

Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy.

Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma.

A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy.

Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy.

HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma.

Response to liposomal doxorubicin and clinical outcome of HIV-1-infected patients with Kaposi's sarcoma receiving highly active antiretroviral therapy.

Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma--associated herpesvirus infection in patients with and without Kaposi sarcoma.

P304

410-417

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/589865

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5272348

http://www.w3.org/2001/XMLSchema#string

P698

18582203

http://www.w3.org/2001/XMLSchema#string

P921